VersaCross® RF Transseptal Solution is intended for left heart access. The VersaCross® RF wire is indicated for creating atrial septal defects in the heart. The VersaCross® Steerable Sheath is indicated for introducing various cardiovascular catheters to the heart, including the left side of the heart through the interatrial septum. In Canada, the VersaCross®️ Large Access Transseptal Dilator is used for the percutaneous introduction of various types of cardiovascular catheters and guidewires to all heart chambers, including the left atrium via transseptal perforation / puncture. In the United States, the VersaCross®️ Large Access Transseptal Dilator is indicated for use in procedures where access to the left atrium via the transseptal technique is desired. Referred to here are examples of several left heart procedures that require transseptal access.
PRM-00829 EN J-1,2 V-1 © Copyright Baylis Medical Company Inc., 2021. Baylis Medical Company Inc. reserves the right to change specifications or to incorporate design changes without notice and without incurring any obligation relating to equipment previously manufactured or delivered. VersaCross, the VersaCross logo, TRUform, TruGlide, Baylis Medical, and the Baylis Medical logo are trademarks and/or registered trademarks of Baylis Medical Company Inc. in the USA and/or other countries. Other trademarks are property of their respective owners. Patents Pending and/or issued. CAUTION: Federal Law (USA) restricts the use of these devices to or by the order of a physician. Before use, consult product labels and Instructions for Use for Indications for Use, Contraindications, Warnings, Precautions, Adverse Events and Directions for Use. Products shown may not be approved in all jurisdictions.